Concomitant use of multiple antipsychotics to treat Schizophrenia: Risk benefit analysis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022
| Glavni autor: | |
|---|---|
| Daljnji autori: | |
| Format: | Disertacija |
| Jezik: | English |
| Izdano: |
Brac University
2024
|
| Teme: | |
| Online pristup: | http://hdl.handle.net/10361/23879 |
| id |
10361-23879 |
|---|---|
| record_format |
dspace |
| spelling |
10361-238792024-08-22T21:05:35Z Concomitant use of multiple antipsychotics to treat Schizophrenia: Risk benefit analysis Tabassum, Fariha Kalam Azad, Dr. Md. Abul School of Pharmacy, Brac University Schizophrenia Antipsychotics Dopamine Serotonin Glutamate Extrapyramidal side effects Schizophrenia This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022 Cataloged from the PDF version of thesis. Includes bibliographical references (pages 56-72). This article discusses about what schizophrenia and its symptoms are and what antipsychotics can be used to treat the disease. The main cause of schizophrenia is not found and some hypothesis and pathways for the disease is considered. The pathways and hypothesis shape the methods applied for the treatment of schizophrenia. Antipsychotics were introduced and these antipsychotics work by blocking some hyperactive receptors like that of dopamine, serotonin. Sometimes patients do not respond to monotherapy of antipsychotics therefore concomitant therapy of antipsychotics are given. This polypharmacy can be helpful in maintenance and treatment for resistant schizophrenia and for reducing side effects. Even though this seems beneficial, it comes with a lot of adverse effects and not all patients respond in the same way. There are not many studies available for the concomitant use of antipsychotics, so this article presents some of the benefits and side effects of the treatment. Fariha Tabassum B. Pharmacy 2024-08-22T09:13:44Z 2024-08-22T09:13:44Z 2022 2022-06 Thesis ID: 18146054 http://hdl.handle.net/10361/23879 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 72 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Schizophrenia Antipsychotics Dopamine Serotonin Glutamate Extrapyramidal side effects Schizophrenia |
| spellingShingle |
Schizophrenia Antipsychotics Dopamine Serotonin Glutamate Extrapyramidal side effects Schizophrenia Tabassum, Fariha Concomitant use of multiple antipsychotics to treat Schizophrenia: Risk benefit analysis |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022 |
| author2 |
Kalam Azad, Dr. Md. Abul |
| author_facet |
Kalam Azad, Dr. Md. Abul Tabassum, Fariha |
| format |
Thesis |
| author |
Tabassum, Fariha |
| author_sort |
Tabassum, Fariha |
| title |
Concomitant use of multiple antipsychotics to treat Schizophrenia: Risk benefit analysis |
| title_short |
Concomitant use of multiple antipsychotics to treat Schizophrenia: Risk benefit analysis |
| title_full |
Concomitant use of multiple antipsychotics to treat Schizophrenia: Risk benefit analysis |
| title_fullStr |
Concomitant use of multiple antipsychotics to treat Schizophrenia: Risk benefit analysis |
| title_full_unstemmed |
Concomitant use of multiple antipsychotics to treat Schizophrenia: Risk benefit analysis |
| title_sort |
concomitant use of multiple antipsychotics to treat schizophrenia: risk benefit analysis |
| publisher |
Brac University |
| publishDate |
2024 |
| url |
http://hdl.handle.net/10361/23879 |
| work_keys_str_mv |
AT tabassumfariha concomitantuseofmultipleantipsychoticstotreatschizophreniariskbenefitanalysis |
| _version_ |
1814309734881165312 |